Incannex Healthcare Share Price and Company Fundamentals



Price
$0.26
Change
-0.020 (-7.143%)
52 week
0.185 - 0.755

Last traded: Today at 6:10 AM

Incannex Healthcare Limited engages in the research, development, and sale of medicinal cannabinoid products in Australia. It offers pharmaceutical grade cannabinoid products under the Incannex brand name. The company's products include IHL-42X, which is in Phase II clinical trials for obstructive sleep apnea; IHL-216A for traumatic brain injury; and IHL-675A, a combination of hydroxychloroquine and cannabidiol for the prevention and treatment of inflammatory lung conditions, such as acute respiratory distress syndrome, chronic obstructive pulmonary disease, asthma, and bronchitis, as well as rheumatoid arthritis and inflammatory bowel diseases. It has partnership with The Alfred Hospital and Novotech on IHL-42X clinical program for obstructive sleep apnea; and Monash Trauma Group at the Department of Neuroscience, Monash University to conduct a study on the protective effect of IHL-216A in sports concussion. The company was formerly known as Impression Healthcare Limited and changed its name to Incannex Healthcare Limited in June 2020. Incannex Healthcare Limited was incorporated in 2001 and is based in Sydney, Australia.

Key Metrics

PE ratio

-

PB ratio

17.12

Dividend yield

0.00%

Beta

2.47

Market cap

-

Enterprise value

-

Company profile

Primary activitiesPharmaceuticals
Industry / SectorDrug Manufacturers—Specialty & Generic / Healthcare
Full time employees3
Websitehttps://www.incannex.com.au
Mailing address207/11 Solent Circuit Norwest Sydney NSW 2153 Australia
Phone / Fax /
Share registryAUTOMIC REGISTRY SERVICES

Dividends

More: Incannex Healthcare Dividend history, yield and payout ratio

Dividend yield

0.00%

Dividend amount

$0.00

Payout ratio

0.00%

Incannex Healthcare paid $0.00 dividend and the ex-dividend date was .The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.IHL dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

IHL's forward dividend amount is $ and the forward dividend yield is . A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Aug 2022, following are the company executives and directors listed on Incannex Healthcare.

NameTitleAgeTotal Pay
Mr. Joel Bradley LathamMD, CEO & Exec. Director31418.36k
Mr. Madhukar BhallaCFO & Company Sec.62
Mr. Lekhram Changoer M.Sc.Chief Technology Officer54
Dr. Mark BleackleyCSO & Member of the Advisory Board
Mr. John Michailidis B.Sc., EMBA, M.A.I.C.D.Chief Exec. Officer of IncannexTM
Ms. Rosemarie WalshClinical Research Mang. & Member of the Advisory Board

Profitability and management effectiveness

Profit margin

0.00%

Operating margin

-1,535.31%

Return on assets

-42.94%

Return on equity

-81.84%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Incannex Healthcare is and its enterprise value is .

The IHL's stocks Beta value is 2.47 making it 147% more volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Incannex Healthcare (IHL)

Incannex Healthcare (ASX:IHL) Frequently Asked Questions

1. What is Incannex Healthcare's Stock Symbol?

Incannex Healthcare trades on ASX under the ticker symbol "IHL".

2. What is Incannex Healthcare's stock price today?

One share of IHL stock can currently be purchased for approximately $0.26.

3. How can I contact Incannex Healthcare?

Incannex Healthcare's mailing address is 207/11 Solent Circuit Norwest Sydney NSW 2153 Australia. The company can be reached via phone at .

4. What is Incannex Healthcare's official website?

The official website of Incannex Healthcare is https://www.incannex.com.au.

5. Which share registry manages Incannex Healthcare's stock?

Incannex Healthcare's stock is managed by AUTOMIC REGISTRY SERVICES.